A protest and die-in during the 13th ICASA gathered more than 100 African activists. They marched, chanting through the conference, stopping at the booths of governments, US government and Pharma. After the action, the activists hold a press conference.
Accueil > Mots-clés > langue > anglais
anglais
Articles
-
« You talk, we die » say African AIDS activists
24 septembre 2003 -
Threat on generic medicines, the European Union ignores it
30 July 2013EU has just modified its legislation on the customs control concerning the enforcement of “intellectual property” rights, not considering that it impedes the legitimate trade of generic medicines in Developing countries.
-
COPY = RIGHT : Let poor countries access generic ARVs
11 juillet 2002Drug companies are using several ways to block generic access in developing countries
-
Foreigners
The Foreigners Commission of Act Up-Paris was created to defend the rights of foreigners living in France who are sick. It contributed in 1997 to having the law include stipulation of the non-deportability of seriously ill people.
-
Act Up-Paris requires Roche to confirm officially its July 22 commitments about Viracept®
23 July 2007On July 23rd, Roche met various HIV community groups, including Act
Up-Paris, at the International AIDS Conference in Sydney. During the
meeting, Roche made certain specific commitments with regard to remedying
the Viracept® recall debacle. Activists require that Roche make these
commitments official. -
European Commission’s pressure on Thailand : Mandelson sacrifices patients
22 août 2007On July 18th 2007, the European Commisoner for Trade wrote a letter to the
governement of Thailand to criticize its access to medicines policy through
compulsory licenses. After being put to pressure by the US drug giant Abbott
Laboratories, Thailand now has to face the pressure of the European Union.The Trade Commissioner’s letter effects a sharp rewrite of actual
international law provisions on access to generic medicines, and expresses
threats against Thailand - all in the interest of the patent-based
pharmaceutical industry, and in complete disregard for the human
consequences of hampering access to affordable lifesaving medication. -
HIV / HCV - Silence = death
21 juillet 20102010/07/21 - Activists against Pharma Greed in the Exhibition Room of the Aids 2010 Conference in Vienna. The first round of protest regarded the HIV/Hepatitis Coinfection issues
HIV-Hepatitis co-infection : the international situation
According to prevalence rates, available only in certain countries, there is an estimated 4 to 5 million HIV-HCV co-infected, baring in mind that a country like Russia still doesn’t hold any relevant data regarding the matter. In Western Europe, the (...) -
French-German summit : financial commitments to fight AIDS must be honored
22 janvier 2003In both Germany and France anti-AIDS activists together ask their governments to commit themselves to fighting the epidemic.
-
Abbott’s management not pleased with Act Up-Paris article ...
4 août 2006The Abbott pharmaceutical company is withdrawing a 4000 euros subsidy it granted to Act Up-Paris - a subsidy intended to sponsor our activity at the international aids conference in Toronto. For what reason ? Because of a recent article published in our journal Protocoles - which provides information about new HIV treatments and research - on a new formula of Norvir, an anti-HIV treatment.
-
Act Up-Paris closes BMS’s booth
22 juillet 2010Today, Act Up-Paris and other activists took possession of Bristol Myers Squibb’s booth during more than half an hour. After having closed the booth, they asked to talk to a representative of the pharma lab.